AMICAS Reports Financial Results for the Second Quarter Ended Jun...(-------- -------- ...),Health
Navigation Links
AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009
Date:8/5/2009
-------- -------- 2009 2008 2009 2008 ---- ---- ---- ---- Net loss $(6,585) $(97) $(7,753) $(564) Provision for income taxes 80 67 133 128 Interest income (104) (572) (550) (1,361) Other income (6) - (6) - Loss on sale of investments - - - 31 Acquisition-related and integration costs 1,096 - 1,645 - Restructuring costs 3,473 - 3,473 Acquisition-related revenue adjustments: Maintenance and services 1,934 - 1,934 - Software licenses and system sales 2,073 - 2,073 - Acquisition-related cost of revenue adjustments (611) - (611) - ---- - ---- - Non-GAAP operating income/(loss) 1,350 (602) 338 (1,766) ----- ---- --- ------ Non-cash stock compensation expense 481 185 938 618 Depreciation 862 170 1,016 338 Amortization 922 678 1,525 1,274 --- --- ----- ----- Adjusted EBITDA 3,615 431 3,817 464 ----- --- ----- --- Three Months Ended Six Months Ended June 30, June 30, -
'/>"/>
| SOURCE AMICAS, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. The Hospital of Central Connecticut Chooses AMICAS
2. Booth Radiology Extends and Elevates Partnership With AMICAS
3. AMICAS Set to Join Russell 3000 Index
4. AMICAS Showcases Vendor-Neutral Archive Solutions at SIIM 2009
5. AMICAS Schedules First Quarter 2009 Earnings Results Conference Call
6. AMICAS Announces General Availability of AMICAS PACS Version 6.0 at HIMSS 2009
7. AMICAS Announces Completion of Merger with Emageon
8. AMICAS Successfully Completes Tender Offer for Shares of Emageon Inc.
9. Australias Healthinc and AMICAS Announce Exclusive Partnership
10. AMICAS Delivers Advanced Integration Framework to Monroe Clinic
11. AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008
Post Your Comments:
(Date:11/22/2009)...ep eating under control, expert says , ,...eason means you,ll be faced with a seemingly endle...mply give in and eat too much, others deny themsel... navigate between overindulgence and deprivation, ...onsult Services at Brigham and Women,s Hospital in...
(Date:11/22/2009)...The holiday season is filled with get-togethers wi...us. It can also be stressful and tiring at times. ...igue, and high fat foods -- factors that can, over...e National Foundation for Cancer Research has deve...ure a happier, more healthful holiday season, and ...
(Date:11/22/2009)... 21 Congressman Chaka F...he United States Senate,s vote tonight to proceed ..., "Senators Arlen Specter and Bob Casey deserve...ns for casting stand-up, critical votes in the Sen...ffordable Health Care Reform legislation to full d...
(Date:11/21/2009)...v. 21 DNC Chairman Tim ...ate voted to begin full debate of health insurance...scom.com/cgi-bin/prnh/20080519/DNCLOGO ) ,, "...e road to enacting health insurance reform. By cle...now have an opportunity to debate the health refor...
(Date:11/21/2009)... 21 Milvia Lopez, by her attorney ...y filed suit, in Supreme Court, New York County, b...that while Ms. Lopez underwent a routine transesop...SPITAL , doctors used an HIV infected scope exposi...several hours after being discharged from the proc...
Breaking Medicine News(10 mins):Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2[0] Go Healthy, Not Hungry for Holiday Eating[0] Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research [0] Congressman Fattah: Thanks to Specter, Casey for a Major Step Along History's Path[0] Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation[0] Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure
...ep in understanding how the nervous system and the...in Institute for Medical Research have identified ...the spleen communicate. , ...nstein Institute for Medical Research have identi...
...to safety; group seeks legislative help , ...y can be nearly silent, hybrid cars pose a serious...impaired people, says the American Council of the ...sually impaired learn to rely on their hearing and...
...thocyanidins are natural, plant-based color...Calif., July 21 ChromaDex Corp., (OTC,Bulletin Bo...ndards and,contract research, announced today its ... the University at Buffalo (SUNY,Buffalo), to prod...
... Inc, (http://www.inutrition.com ) and InterACTIVE...com ) subsidiaries of Natural Nutrition, Inc, (OTC...mpanies have inked an,agreement with actor John O,...rnet video campaign. Mr. O,Hurley is bringing,his ...
...c and Orthopedic Hospital of Chicago offers inform.... Available as a laminated card or downloadable p...sks, including knee-specific strengthening exercis...ament (ACL) every year. That's double the nu...
...ss surgery, researchers say , , FRIDAY, Ju...e grown in mice the kind of functioning heart bloo... operations. , One ultimate goal is to replace som... hearts that need more oxygen, said Juan M. Melero...
Other Medicine News:Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 2Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 3Health News:Hybrid Cars Pose Risk to Blind, Visually Impaired 2Health News:ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds 2Health News:ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds 3Health News:iNutrition Signs John O'Hurley to Launch New Internet Video Campaign 2Health News:Complimentary Sports Injury Prevention Pamphlet for Women Offered by NOHC of Chicago 2Health News:Complimentary Sports Injury Prevention Pamphlet for Women Offered by NOHC of Chicago 3Health News:Heart Blood Vessels Grown in the Lab 2Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease Hybrid Cars Pose Risk to Blind, Visually ImpairedChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit CompoundsiNutrition Signs John O'Hurley to Launch New Internet Video CampaignComplimentary Sports Injury Prevention Pamphlet for Women Offered by NOHC of ChicagoHeart Blood Vessels Grown in the Lab
(Date:11/20/2009)...wswire-FirstCall/ -- Biotel Inc. (OTC Bulletin Boa...ended September 30, 2009 with net earnings of $128...3,263,000. This compares to net earnings of $328,...,168,000 for the first quarter of last year. ,,...resident and CEO Steve Springrose said: "Biotel en...
(Date:11/20/2009)... Smith & Nephew ( SNN...ounce the signing of a technology development cont...that may lead to the creation of a fracture fixati...of the limbs of soldiers who sustain battlefield i...earch Projects Agency (DARPA), the central researc...
(Date:11/19/2009)...Newswire/ -- In response to an ever-increasing num...dicines, Operation Pangea II, involving 24 countri...th Organization,s International Medical Products A... the dangers of buying medicines online. ,, The...of arrests and the seizure of thousands of potenti...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status 5522 1Paradigm shift needed to combat drug resistance 59596 1Paradigm shift needed to combat drug resistance 59596 2Physical therapists play integral role in prevention risk reduction and treatment of lymphedema 59594 1Physical therapists play integral role in prevention risk reduction and treatment of lymphedema 59594 2Physical therapists play integral role in prevention risk reduction and treatment of lymphedema 59594 3...hase II Results of Roche and Ipsen,s First Once-We...betes Association Meeting -, NUTLEY, N.J., June 1...es drug taspoglutide (R1583) has been shown to pro...nd weight loss after only,eight weeks of treatment...supports entry into Phase III. Taspoglutide, origi...
...l Results Expected in Q3 2008, Conference Call to...ern Time, MOUNTA...nc. (Nasdaq: ALXA ) announced today that it has c...trial with AZ-004 (Staccato(R),loxapine). AZ-004 i...for,the treatment of acute agitation in patients w...
Other Medicine Technology:Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 7Straight Iris Scissors (Ring Handle)
Surpass Superfusion
...es its hallmark 50 and 100 ms scans to perform tru...scan protocols and proprietary cardiac analysis so...targets and two x-ray detector rings to image the ...ial perfusion and wall motion. The EBT C300 also s...
Corneal Scissors (Westcott Straight Tenotomy Scissors)
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |